We are live on ! Find out more
Citadel Advisors

Citadel Advisors Portfolio holdings

AUM $618B
1-Year Est. Return 30.34%
 

Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.

This Fund
S&P 500
This Quarter Est. Return
+15.45%
1 Year Est. Return
+30.34%
3 Year Est. Return
+94.87%
5 Year Est. Return
+105.94%
10 Year Est. Return
+433.28%
AUM
$201B
AUM Growth
+$18.3B
Cap. Flow
-$12.7B
Cap. Flow %
-6.33%
Top 10 Hldgs %
24.23%
Holding
10,449
New
1,430
Increased
3,737
Reduced
3,810
Closed
1,252

Top Buys

Rank Stock Value
1
DIS icon
Walt Disney
DIS
+$415M
2
LLY icon
Eli Lilly
LLY
+$402M
3
GS icon
Goldman Sachs
GS
+$384M
4
MCD icon
McDonald's
MCD
+$379M
5
TSLA icon
Tesla
TSLA
+$304M

Top Sells

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$1.98B
2
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$596M
3
T icon
AT&T
T
+$460M
4
SYF icon
Synchrony
SYF
+$398M
5
HON icon
Honeywell
HON
+$342M

Sector Composition

Rank Sector Weight
1 Technology 5.53%
2 Financials 4.78%
3 Healthcare 3.89%
4 Industrials 3.6%
5 Consumer Discretionary 3.37%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
INO icon
8501
CALL
Inovio Pharmaceuticals
INO
$57.3M
$71K ﹤0.01%
1,592
-483
-23% -$24.3K
RIGL icon
8502
CALL
Rigel Pharmaceuticals
RIGL
$693M
$71K ﹤0.01%
+2,760
New +$63.1K
SMFG icon
8503
Sumitomo Mitsui Financial
SMFG
$160B
$71K ﹤0.01%
10,083
-34,260
-77% -$245K
RRTS
8504
DELISTED
RoadRunner Transportation Systems, Inc.
RRTS
$71K ﹤0.01%
6,784
+6,065
+844% +$74.1K
FTEK icon
8505
Fuel Tech
FTEK
$46.7M
$70K ﹤0.01%
41,631
+23,610
+131% +$31K
HIO
8506
Western Asset High Income Opportunity Fund
HIO
$336M
$70K ﹤0.01%
+14,423
New +$68.6K
SUP
8507
DELISTED
Superior Industries International
SUP
$70K ﹤0.01%
14,745
-161,348
-92% -$863K
TURN
8508
CALL
DELISTED
180 Degree Capital
TURN
$70K ﹤0.01%
12,600
-13,633
-52% -$78.5K
UOKA
8509
DELISTED
MDJM Ltd
UOKA
$70K ﹤0.01%
+23
New +$79.5K
IDEX
8510
CALL
DELISTED
Ideanomics, Inc. Common Stock
IDEX
$70K ﹤0.01%
290
-88
-23% -$16.6K
AVH
8511
DELISTED
AVIANCA HOLDINGS S.A.
AVH
$70K ﹤0.01%
17,154
+4,980
+41% +$22.8K
VVUS
8512
CALL
DELISTED
Vivus Inc
VVUS
$70K ﹤0.01%
+16,700
New +$74.4K
BTE icon
8513
PUT
Baytex Energy
BTE
$3.12B
$69K ﹤0.01%
40,700
-20,200
-33% -$35.4K
BTG icon
8514
CALL
B2Gold
BTG
$5.13B
$69K ﹤0.01%
24,500
+1,100
+5% +$3.28K
CLSD
8515
DELISTED
Clearside Biomedical
CLSD
$69K ﹤0.01%
3,341
-927
-22% -$18.4K
CVM icon
8516
CEL-SCI Corp
CVM
$21.8M
$69K ﹤0.01%
+646
New +$55.4K
FPI
8517
CALL
Farmland Partners
FPI
$418M
$69K ﹤0.01%
+10,800
New +$61.3K
ACH
8518
CALL
Accendra Health
ACH
$261M
$69K ﹤0.01%
+16,900
New +$107K
TWI icon
8519
CALL
Titan International
TWI
$466M
$69K ﹤0.01%
+11,600
New +$65.4K
ATHX
8520
DELISTED
Athersys, Inc. Common Stock
ATHX
$69K ﹤0.01%
1,840
-3,451
-65% -$132K
ZN
8521
CALL
DELISTED
Zion Oil & Gas, Inc.
ZN
$69K ﹤0.01%
91,900
-357,500
-80% -$197K
CMRE icon
8522
PUT
Costamare
CMRE
$1.87B
$68K ﹤0.01%
13,100
-5,600
-30% -$28.2K
CPRX
8523
PUT
DELISTED
Catalyst Pharmaceutical
CPRX
$68K ﹤0.01%
+13,300
New +$39.1K
CRIS icon
8524
CALL
Curis
CRIS
$10M
$68K ﹤0.01%
85
-24
-22% -$11.5K
GERN icon
8525
CALL
Geron
GERN
$821M
$68K ﹤0.01%
40,900
-66,900
-62% -$91.4K

Similar funds

Citadel Advisors's Q1 2019 Portfolio in Review

As of Q1 2019, Citadel Advisors held 10,449 positions worth $201B, up 10% from $183B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Citadel Advisors withdrew a net $12.7B in Q1 2019, closing 1,252 positions and reducing 3,810 holdings. Its most notable exit was Twenty-First Century Fox, Inc. Class A, an estimated $223M position sold in full.

By sector, the portfolio is most concentrated in Technology at 5.5% of assets, up from 4.5% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Citadel Advisors opened a new position in Elanco Animal Health worth $251M.

  • Citadel Advisors's largest Q1 2019 buy was Elanco Animal Health: 7,832,197 shares worth $251M.
  • Citadel Advisors added most to Walt Disney in Q1 2019, an estimated $415M increase.
  • Citadel Advisors's biggest Q1 2019 reduction was Amazon, cutting an estimated $1.98B.
  • Citadel Advisors fully exited Twenty-First Century Fox, Inc. Class A in Q1 2019, selling an estimated $223M.
  • Citadel Advisors's ten largest holdings make up 24% of its $201B portfolio in Q1 2019.
  • Citadel Advisors opened 1,430 new positions and closed 1,252 in Q1 2019.
  • Citadel Advisors's portfolio value rose 10% quarter-over-quarter to $201B.

Based on Citadel Advisors's 13F filing for Q1 2019, filed 15 May 2019.